123 related articles for article (PubMed ID: 32573082)
1. Genetic aberrations involved in relapse of pediatric acute myeloid leukemia: A literature review.
Zafar N; Ghias K; Fadoo Z
Asia Pac J Clin Oncol; 2021 Oct; 17(5):e135-e141. PubMed ID: 32573082
[TBL] [Abstract][Full Text] [Related]
2. Genomic Profiling of Pediatric Acute Myeloid Leukemia Reveals a Changing Mutational Landscape from Disease Diagnosis to Relapse.
Farrar JE; Schuback HL; Ries RE; Wai D; Hampton OA; Trevino LR; Alonzo TA; Guidry Auvil JM; Davidsen TM; Gesuwan P; Hermida L; Muzny DM; Dewal N; Rustagi N; Lewis LR; Gamis AS; Wheeler DA; Smith MA; Gerhard DS; Meshinchi S
Cancer Res; 2016 Apr; 76(8):2197-205. PubMed ID: 26941285
[TBL] [Abstract][Full Text] [Related]
3. Genomic complexity and dynamics of clonal evolution in childhood acute myeloid leukemia studied with whole-exome sequencing.
Masetti R; Castelli I; Astolfi A; Bertuccio SN; Indio V; Togni M; Belotti T; Serravalle S; Tarantino G; Zecca M; Pigazzi M; Basso G; Pession A; Locatelli F
Oncotarget; 2016 Aug; 7(35):56746-56757. PubMed ID: 27462774
[TBL] [Abstract][Full Text] [Related]
4. Profiling of somatic mutations in acute myeloid leukemia with FLT3-ITD at diagnosis and relapse.
Garg M; Nagata Y; Kanojia D; Mayakonda A; Yoshida K; Haridas Keloth S; Zang ZJ; Okuno Y; Shiraishi Y; Chiba K; Tanaka H; Miyano S; Ding LW; Alpermann T; Sun QY; Lin DC; Chien W; Madan V; Liu LZ; Tan KT; Sampath A; Venkatesan S; Inokuchi K; Wakita S; Yamaguchi H; Chng WJ; Kham SK; Yeoh AE; Sanada M; Schiller J; Kreuzer KA; Kornblau SM; Kantarjian HM; Haferlach T; Lill M; Kuo MC; Shih LY; Blau IW; Blau O; Yang H; Ogawa S; Koeffler HP
Blood; 2015 Nov; 126(22):2491-501. PubMed ID: 26438511
[TBL] [Abstract][Full Text] [Related]
5. High-frequency type I/II mutational shifts between diagnosis and relapse are associated with outcome in pediatric AML: implications for personalized medicine.
Bachas C; Schuurhuis GJ; Hollink IH; Kwidama ZJ; Goemans BF; Zwaan CM; van den Heuvel-Eibrink MM; de Bont ES; Reinhardt D; Creutzig U; de Haas V; Assaraf YG; Kaspers GJ; Cloos J
Blood; 2010 Oct; 116(15):2752-8. PubMed ID: 20592250
[TBL] [Abstract][Full Text] [Related]
6. High WT1 mRNA expression after induction chemotherapy and FLT3-ITD have prognostic impact in pediatric acute myeloid leukemia: a study of the Japanese Childhood AML Cooperative Study Group.
Shimada A; Taki T; Koga D; Tabuchi K; Tawa A; Hanada R; Tsuchida M; Horibe K; Tsukimoto I; Adachi S; Kojima S; Hayashi Y
Int J Hematol; 2012 Oct; 96(4):469-76. PubMed ID: 22915059
[TBL] [Abstract][Full Text] [Related]
7. Integrative analysis of type-I and type-II aberrations underscores the genetic heterogeneity of pediatric acute myeloid leukemia.
Balgobind BV; Hollink IH; Arentsen-Peters ST; Zimmermann M; Harbott J; Beverloo HB; von Bergh AR; Cloos J; Kaspers GJ; de Haas V; Zemanova Z; Stary J; Cayuela JM; Baruchel A; Creutzig U; Reinhardt D; Pieters R; Zwaan CM; van den Heuvel-Eibrink MM
Haematologica; 2011 Oct; 96(10):1478-87. PubMed ID: 21791472
[TBL] [Abstract][Full Text] [Related]
8. What Is Abnormal in Normal Karyotype Acute Myeloid Leukemia in Children? Analysis of the Mutational Landscape and Prognosis of the TARGET-AML Cohort.
Herlin MK; Yones SA; Kjeldsen E; Holmfeldt L; Hasle H
Genes (Basel); 2021 May; 12(6):. PubMed ID: 34064268
[TBL] [Abstract][Full Text] [Related]
9. Cooperating mutations of receptor tyrosine kinases and Ras genes in childhood core-binding factor acute myeloid leukemia and a comparative analysis on paired diagnosis and relapse samples.
Shih LY; Liang DC; Huang CF; Chang YT; Lai CL; Lin TH; Yang CP; Hung IJ; Liu HC; Jaing TH; Wang LY; Yeh TC
Leukemia; 2008 Feb; 22(2):303-7. PubMed ID: 17960171
[TBL] [Abstract][Full Text] [Related]
10. Stability and prognostic influence of FLT3 mutations in paired initial and relapsed AML samples.
Cloos J; Goemans BF; Hess CJ; van Oostveen JW; Waisfisz Q; Corthals S; de Lange D; Boeckx N; Hählen K; Reinhardt D; Creutzig U; Schuurhuis GJ; Zwaan ChM; Kaspers GJ
Leukemia; 2006 Jul; 20(7):1217-20. PubMed ID: 16642044
[TBL] [Abstract][Full Text] [Related]
11. Uncovering the Genomic Landscape in Newly Diagnosed and Relapsed Pediatric Cytogenetically Normal FLT3-ITD AML.
Buelow DR; Pounds SB; Wang YD; Shi L; Li Y; Finkelstein D; Shurtleff S; Neale G; Inaba H; Ribeiro RC; Palumbo R; Garrison D; Orwick SJ; Blachly JS; Kroll K; Byrd JC; Gruber TA; Rubnitz JE; Baker SD
Clin Transl Sci; 2019 Nov; 12(6):641-647. PubMed ID: 31350825
[TBL] [Abstract][Full Text] [Related]
12. Analysis of FLT3-Activating Mutations in Patients With Acute Myelogenous Leukemia in Jordan: Association With FAB Subtypes and Identification of Subgroups With Poor Prognosis.
Halahleh K; Taqash A; Abdelkhaleq H; Manasrah M; Marie L; Al-Rabi K
Clin Lymphoma Myeloma Leuk; 2021 Jul; 21(7):e588-e597. PubMed ID: 33811005
[TBL] [Abstract][Full Text] [Related]
13. Clinical relevance of molecular aberrations in paediatric acute myeloid leukaemia at first relapse.
Bachas C; Schuurhuis GJ; Reinhardt D; Creutzig U; Kwidama ZJ; Zwaan CM; van den Heuvel-Eibrink MM; De Bont ES; Elitzur S; Rizzari C; de Haas V; Zimmermann M; Cloos J; Kaspers GJ
Br J Haematol; 2014 Sep; 166(6):902-10. PubMed ID: 24962064
[TBL] [Abstract][Full Text] [Related]
14. [Mutational Profiling of Pediatric Myeloid Leukemia Subtypes without Clinically Significant Chromosomal Aberrations].
Ghukasyan LG; Krasnov GS; Muravenko OV; Baidun LV; Ibragimova SZ; Nasedkina TV
Mol Biol (Mosk); 2019; 53(3):402-410. PubMed ID: 31184605
[TBL] [Abstract][Full Text] [Related]
15. The role of minor subpopulations within the leukemic blast compartment of AML patients at initial diagnosis in the development of relapse.
Bachas C; Schuurhuis GJ; Assaraf YG; Kwidama ZJ; Kelder A; Wouters F; Snel AN; Kaspers GJ; Cloos J
Leukemia; 2012 Jun; 26(6):1313-20. PubMed ID: 22289983
[TBL] [Abstract][Full Text] [Related]
16. The effect of the detection of minimal residual disease for the prognosis and the choice of post-remission therapy of intermediate-risk acute myeloid leukemia without FLT3-ITD, NPM1 and biallelic CEBPA mutations.
Zheng WS; Hu YL; Guan LX; Peng B; Wang SY
Hematology; 2021 Dec; 26(1):179-185. PubMed ID: 33594943
[TBL] [Abstract][Full Text] [Related]
17. AML patients with CEBPalpha mutations mostly retain identical mutant patterns but frequently change in allelic distribution at relapse: a comparative analysis on paired diagnosis and relapse samples.
Shih LY; Liang DC; Huang CF; Wu JH; Lin TL; Wang PN; Dunn P; Kuo MC; Tang TC
Leukemia; 2006 Apr; 20(4):604-9. PubMed ID: 16453003
[TBL] [Abstract][Full Text] [Related]
18. Clonal evolution of acute myeloid leukemia from diagnosis to relapse.
Vosberg S; Greif PA
Genes Chromosomes Cancer; 2019 Dec; 58(12):839-849. PubMed ID: 31478278
[TBL] [Abstract][Full Text] [Related]
19. Genetic mechanisms of primary chemotherapy resistance in pediatric acute myeloid leukemia.
McNeer NA; Philip J; Geiger H; Ries RE; Lavallée VP; Walsh M; Shah M; Arora K; Emde AK; Robine N; Alonzo TA; Kolb EA; Gamis AS; Smith M; Gerhard DS; Guidry-Auvil J; Meshinchi S; Kentsis A
Leukemia; 2019 Aug; 33(8):1934-1943. PubMed ID: 30760869
[TBL] [Abstract][Full Text] [Related]
20. Gene expression profiles associated with pediatric relapsed AML.
Bachas C; Schuurhuis GJ; Zwaan CM; van den Heuvel-Eibrink MM; den Boer ML; de Bont ES; Kwidama ZJ; Reinhardt D; Creutzig U; de Haas V; Kaspers GJ; Cloos J
PLoS One; 2015; 10(4):e0121730. PubMed ID: 25849371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
